Heart Disease News and Research

Latest Heart Disease News and Research

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Sinobiopharma, Inc., an innovative biopharmaceutical products company with primary operations in China, today announced that the Company, through its wholly-owned subsidiary Dong Ying Pharmaceutical Co., Ltd., has signed an agreement with Jiangsu Lianhuan Pharmaceuticals Co., Ltd. to co-develop, manufacture and commercialize Eplerenone, a therapeutic agent formulated to treat high blood pressure and vascular diseases.

11 Aug 2010

Stanford Hospital & Clinics establishes Kidney and Pancreas Transplant Clinic at Salinas Valley Memorial

The partnership between Salinas Valley Memorial Healthcare System and Stanford Hospital & Clinics has added another facet of care, bringing world-class organ transplant care to patients on the Central Coast. Stanford's Adult Kidney and Pancreas Transplant Program will begin seeing patients at Salinas Valley Memorial's Ryan Ranch facility.

11 Aug 2010

Cord Blood America to begin sale of DNA Predisposition testing services

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that within 90 days it will begin selling DNA Predisposition testing services in conjunction with The DNA Shop, LLC,Henderson, Nevada.

11 Aug 2010

Insuring your health: Health law expands Medicare coverage of preventive care

In her latest Kaiser Health News consumer column, Michelle Andrews writes: "Preventive health care is important at any age, but never more so than as we get older.

11 Aug 2010

Acute aortic dissection program reduces diagnosis time in AAD patients

Using a standardized protocol within a regional health network, a multidisciplinary acute aortic dissection (AAD) program resulted in a 43 percent reduction in time to diagnosis for all AAD patients over the course of five years, based on study results published in the July edition of Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

11 Aug 2010

Enriched breakfast re-energizes children's morning rituals and boosts learning potential

As the lazy days of summer vacation begin to come to a close, it's time to start thinking about re-formulating and re-energizing morning rituals that can help boost your child's learning potential.

11 Aug 2010

Spinal muscular atrophy may lead to cardiac dysfunction: Study

Along with skeletal muscles, it may be important to monitor heart function in patients with spinal muscular atrophy (SMA). These are the findings from a study conducted by Nationwide Children's Hospital and published online ahead of print in Human Molecular Genetics. This is the first study to report cardiac dysfunction in mouse models of SMA.

11 Aug 2010

Acoustic cardiography improves diagnostic accuracy in acute heart failure

It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.It allows them to hear the S3, an abnormal third sound in the heart's rhythm strongly associated with cardiac disease and heart failure. However, the low-frequency, low-pitch sound is notoriously very difficult to hear with a stethoscope alone.

11 Aug 2010

Study shows physicians reluctant to use finasteride for prostate cancer

Despite the dramatic results of the Prostate Cancer Prevention Trial (PCPT), which showed a significant reduction in prostate cancer among those taking finasteride, physicians have not increased its use, according to a study published in the September issue of Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

11 Aug 2010

Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.

Labopharm Inc. today announced that OLEPTRO(TM) (trazodone hydrochloride extended-release tablets), a novel once-daily formulation of the antidepressant trazodone, has been launched in the United States by its joint venture with Gruppo Angelini, Angelini Labopharm. OLEPTRO(TM) is indicated for the treatment of major depressive disorder (MDD) in adults. The efficacy of OLEPTRO(TM) has been established in a trial of outpatients with MDD as well as in trials with the immediate release formulation of trazodone.

11 Aug 2010

Progestins have tumor-stage specific effects that determine promotion, suppression: Study

Progestins are used in hormone replacement therapies to counteract the negative effects of estrogen on the uterus and reduce the risk of uterine cancer. However, evidence in recent studies and clinical trials has demonstrated that progestins increase the risk of breast cancer. Now, University of Missouri researchers have compared four types of progestins used in hormone replacement therapies and found significantly different outcomes on the progression of breast cancer in an animal model depending on the type of progestins used.

11 Aug 2010

Cardiovascular Systems fourth-quarter revenue increases 15% to $18.0 million

Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional treatment systems for vascular disease, today reported financial results for its fiscal fourth quarter and year ended June 30, 2010.

11 Aug 2010

Noven enters agreement to acquire global rights to ADHD drug Daytrana from Shire

Noven Pharmaceuticals, Inc. today announced that it has entered into a Product and Trademark Acquisition Agreement with affiliates of Shire plc pursuant to which Noven will acquire global rights to Daytrana® (methylphenidate transdermal system) from Shire.

11 Aug 2010

Telephone monitoring can save heart failure patients: Study

Chronic heart failure needs constant care and regular monitoring. Now research says remote monitoring, either over the phone or using wireless technology, helps people with heart failure live longer and stay out of hospital.

10 Aug 2010

Atrium awarded 3-year national contract from Premier for surgical mesh products

Atrium Medical Corporation, pioneering advancements in biological, mechanical and therapeutic solutions for soft tissue reinforcement, is proud to announce that the company was awarded a three-year national contract from Premier Purchasing Partners L.P., the group purchasing organization of Premier, Inc. (Charlotte, NC).

10 Aug 2010

Response Biomedical second-quarter revenue from product sales increases 2%

Response Biomedical Corporation today announced financial results for the second quarter and six months ended June 30, 2010.

10 Aug 2010

Theragenics reports consolidated revenue of $20.8M for second-quarter 2010

Theragenics Corporation, a medical device company serving the surgical products and prostate cancer treatment markets, today announced consolidated financial results for the second quarter ended June 30, 2010.

10 Aug 2010

First Edition: August 10, 2010

In today's news, the House is back in town... though just for a day. Lawmakers will consider a state aid package that includes $16 billion in federal Medicaid assistance.

10 Aug 2010

Analytics helps solve critical cardiovascular service line problems

Do you know if your labs are providing the appropriate evidence-based care? Can you uncover root causes beneath changes in volume and outcome patterns? Can you track whether your heart program is slowing or growing, profitable or not? LUMEDX healthcare analytics can help.

10 Aug 2010

Amarin provides progress update on MARINE and ANCHOR trials for treating elevated triglyceride levels

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.

10 Aug 2010

Heart Disease News and Research

Latest Heart Disease News and Research

Sinobiopharma inks agreement with Lianhuan to co-develop, manufacture and commercialize Eplerenone

Stanford Hospital & Clinics establishes Kidney and Pancreas Transplant Clinic at Salinas Valley Memorial

Cord Blood America to begin sale of DNA Predisposition testing services

Insuring your health: Health law expands Medicare coverage of preventive care

Acute aortic dissection program reduces diagnosis time in AAD patients

Enriched breakfast re-energizes children's morning rituals and boosts learning potential

Spinal muscular atrophy may lead to cardiac dysfunction: Study

Acoustic cardiography improves diagnostic accuracy in acute heart failure

Study shows physicians reluctant to use finasteride for prostate cancer

Labopharm launches antidepressant OLEPTRO for major depressive disorder in U.S.

Progestins have tumor-stage specific effects that determine promotion, suppression: Study

Cardiovascular Systems fourth-quarter revenue increases 15% to $18.0 million

Noven enters agreement to acquire global rights to ADHD drug Daytrana from Shire

Telephone monitoring can save heart failure patients: Study

Atrium awarded 3-year national contract from Premier for surgical mesh products

Response Biomedical second-quarter revenue from product sales increases 2%

Theragenics reports consolidated revenue of $20.8M for second-quarter 2010

First Edition: August 10, 2010

Analytics helps solve critical cardiovascular service line problems

Amarin provides progress update on MARINE and ANCHOR trials for treating elevated triglyceride levels

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Heart Disease News and Research

Latest Heart Disease News and Research

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in